Nifty Pharma index declined 1.5 per cent in trade after US President Donald Trump warned to impose a 25 per cent tariff on ...

Indian group’s in-house R&D, manufacturing and global marketing expertise could prove highly valuable to Adcock ...

The group acknowledges limited growth in South Africa’s price-regulated pharma market but believes Natco’s backing will ...

Hyderabad: NATCO Pharma Limited has announced that the U.S. Food and Drug Administration (USFDA) has issued an Establishment ...

Pharmaceutical stocks came under pressure on Thursday, July 31, after US President Donald Trump announced a sweeping 25% ...

In a week marked by mounting tension between rival suitors, the battle for control of JSE-listed MAS PLC — owner of a R32bn ...

Natco Pharma informed that the U.S. Food and Drug Administration (US FDA) has issued an EIR for its active pharmaceutical ingredient (API) division located in Mekaguda, Hyderabad, Telangana.

The U.S. FDA had inspected the API facility, in Mekaguda here, from June 9-13 and issued Form 483 with one observation. The regulator had classified it as “voluntary action indicated” (VAI), the ...

Indian markets initially stumbled but recovered following Trump's tariff announcement, with export-heavy sectors like textiles, pharma, and auto facing the brunt. While some companies anticipate ...

The market may open lower Thursday due to Trump's 25% tariff on Indian goods and penalties for trade with Russia.

Indian stock markets opened sharply lower on Thursday following US President Donald Trump’s announcement of a 25 per cent tariff on Indian goods, along with penalties related to purchases of Russian ...

The Nifty Pharma index closed 0.54 per cent up at 22662.7. Benchmark NSE Nifty50 index ended down 225.1 points at 24837.0, ...